1.Application of magnifying chromoendoscopy in endoscopic mucosal resection of colorectal neoplasms
Xiaobo LI ; Huimin CHEN ; Yunjie GAO ; Lei SHEN ; Hanbing XUE ; Wenjia ZHAO ; Xiaoyu CHEN ; Zhizheng GE
Chinese Journal of Digestion 2010;30(1):7-10
Objective To evaluate the clinical efficacy and safety of endoscopic mucosal resection (EMR) assisted with magnifying chromoendoscopy in treatment of colorectal neoplasms. Methods Patients who met criteria for EMR including appropriate flat or depressed type and sessile lesions were enrolled. The association of morphology of colorectal lesions with histopathology was observed and the accuracy of estimation of invasive depth by magnifying chromoendoscopy was evaluated. Results Ninety lesions of 81 patients were reseeted by EMR (25 being sessile and 65 being flat or depressed). The histological results revealed low-grade dysplasia (LGD) in 58 lesions, high-grade dysplasia (HGD) in 20 lesions, and adenocarcinoma in 12 lesions. The average size of lesions was (1.4±0.5) cm in HGD, (1.6±0.5) cm in cancer and (1.0±0.4) cm in LGD with no significant difference (P> 0.05). It was shown that the flat and depressed lesions were more likely to be HGD or cancer as compared to sessile lesions, but with no statistical difference [41.5 % (27/65)vs. 20.0% (5/25), P= 0.084]. Moreover, the lesion with central depression was more likely to be HGD or cancer as compared to those without depressed surface [51.0% (25/49) vs. 17.1 % (7/41), P<0.01)]. The accuracy of estimating invasive depth by magnifying chromoendoscopy was 97.8% (86/90). Complete resection was confirmed histologically in 95.8% (88/90) of all lesions. Conclusions Colorectal lesions of depressed and flat types with central depression are more likely to be malignant. Estimation of invasive depth of colorectal neoplasia by magnifying chromoendoscopy in EMR treatment makes it more effective and safer.
2.Caspase Recruitment Domain Containing Protein 9 Suppresses Non-Small Cell Lung Cancer Proliferation and Invasion via Inhibiting MAPK/p38 Pathway
Linyue PAN ; Yuting TAN ; Bin WANG ; Wenjia QIU ; Yulei YIN ; Haiyan GE ; Huili ZHU
Cancer Research and Treatment 2020;52(3):867-885
Purpose:
Caspase recruitment domain containing protein 9 (CARD9) has been demonstrated to be a pro-tumor factor in various cancers. However, our previous study found a significant decrease of CARD9 in malignant pleural effusion compared with benign pleural effusion. So we investigated the role of CARD9 in non-small cell lung cancer (NSCLC) and its working mechanism.
Materials and Methods:
Immunohistochemistry, western blot, and quantitative real-time polymerase chain reaction were used to detect the expression of CARD9 in specimens of NSCLC patients. The Cancer Genome Atlas (TCGA) databasewas also used to analyze the expression of CARD9 in NSCLC and its predicting value for prognosis. Immunofluorescence was used for CARD9 cellular location. Cell growth assay, clonal formation assay, wound healing assay, matrigel invasion assay, and flow cytometry were used to test cell proliferation, migration, invasion, apoptosis, and cycle progression of NSCLC cells with CARD9 knockdown or CARD9 overexpression. Co-immunoprecipitation was used to identify the interaction between CARD9 and B-cell lymphoma 10 (BCL10). SB203580 was used to inhibit p38 activation.
Results:
CARD9 was decreased in NSCLC tissues compared with normal tissues; low CARD9 expression was associated with poor survival. CARD9 was expressed both in tumor cells and macrophages. Downregulation of CARD9 in NSCLC cells enhanced the abilities of proliferation, invasion and migration via activated MAPK/p38 signaling, while overexpression of CARD9 presented antitumor effects. BCL10 was identified to interact with CARD9.
Conclusion
We demonstrate that CARD9 is an independent prognostic factor in NSCLC patients and inhibits proliferation, migration, and invasion by suppressing MAPK/p38 pathway in NSCLC cells.
3.Phenylpropanoid pathway in plants and its role in response to heavy metal stress: a review.
Wenjia GE ; Jianpan XIN ; Runan TIAN
Chinese Journal of Biotechnology 2023;39(2):425-445
Phenylpropanoid metabolic pathway is one of the most important secondary metabolic pathways in plants. It directly or indirectly plays an antioxidant role in plant resistance to heavy metal stress, and can improve the absorption and stress tolerance of plants to heavy metal ions. In this paper, the core reactions and key enzymes of the phenylpropanoid metabolic pathway were summarized, and the biosynthetic processes of key metabolites such as lignin, flavonoids and proanthocyanidins and relevant mechanisms were analyzed. Based on this, the mechanisms of key products of phenylpropanoid metabolic pathway in response to heavy metal stress were discussed. The perspectives on the involvement of phenylpropanoid metabolism in plant defense against heavy metal stress provides a theoretical basis for improving the phytoremediation efficiency of heavy metal polluted environment.
Plants/metabolism*
;
Metals, Heavy/metabolism*
;
Flavonoids/metabolism*
;
Biodegradation, Environmental
;
Antioxidants
4.Persisting lung pathogenesis and minimum residual virus in hamster after acute COVID-19.
Lunzhi YUAN ; Huachen ZHU ; Ming ZHOU ; Jian MA ; Rirong CHEN ; Liuqin YU ; Wenjia CHEN ; Wenshan HONG ; Jia WANG ; Yao CHEN ; Kun WU ; Wangheng HOU ; Yali ZHANG ; Shengxiang GE ; Yixin CHEN ; Quan YUAN ; Qiyi TANG ; Tong CHENG ; Yi GUAN ; Ningshao XIA
Protein & Cell 2022;13(1):72-77
Animals
;
Antibodies, Neutralizing/biosynthesis*
;
Antibodies, Viral/biosynthesis*
;
Body Weight/immunology*
;
COVID-19/virology*
;
Disease Models, Animal
;
Disease Progression
;
Humans
;
Immunohistochemistry
;
Lung/virology*
;
Male
;
Mesocricetus
;
Nasal Cavity/virology*
;
RNA, Viral/immunology*
;
SARS-CoV-2/pathogenicity*
;
Severity of Illness Index
;
Viral Load